Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands
- PMID: 2951601
- DOI: 10.1007/BF00177711
Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands
Abstract
In order to test the hypothesis emerging from the literature that 3H-sulpiride and 3H-spiperone might label different subclasses of dopamine D2 receptors in the brain, the binding properties of the two ligands were compared under optimized conditions. 3H-sulpiride was found to show a very fast rate of dissociation from the receptor. Furthermore, with this ligand, an apparently "specific" binding to glass fiber filters was observed. A centrifugation assay was therefore used for the characterization of 3H-sulpiride binding. The binding of 3H-spiperone was measured in a way which prevented its attachment to sites other than D2 receptors. Under these conditions, the two ligands were found to label identical dopaminergic recognition sites (D2 receptors) according to the following criteria: 3H-sulpiride and 3H-spiperone both labelled only one single site with a comparable density. Identical changes in the receptor number for both ligands were found in the tissue from animals with nigrostriatal 6-hydroxydopamine lesions. The potencies of various dopamine agonists and antagonists in displacing 3H-sulpiride or 3H-spiperone from their binding sites showed a highly significant one to one correlation. Finally, the binding of both ligands could be inactivated by pretreatment of the membranes with N-ethylmaleimide, with or without Na+-ions being present. This inactivation followed exactly the same kinetics for both radioligands. Thus, no indication supporting the hypothesis that 3H-sulpiride and 3H-spiperone might label different subsets of dopamine D2 receptors in the rat brain could be found.
Similar articles
-
Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.Eur J Pharmacol. 1982 Jul 9;81(2):273-85. doi: 10.1016/0014-2999(82)90445-9. Eur J Pharmacol. 1982. PMID: 7117377
-
Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.Proc Natl Acad Sci U S A. 1981 Apr;78(4):2620-4. doi: 10.1073/pnas.78.4.2620. Proc Natl Acad Sci U S A. 1981. PMID: 6941314 Free PMC article.
-
Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.J Pharmacol Exp Ther. 1983 Dec;227(3):592-9. J Pharmacol Exp Ther. 1983. PMID: 6655559
-
Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.Brain Res. 1990 Apr 23;514(1):93-102. doi: 10.1016/0006-8993(90)90439-i. Brain Res. 1990. PMID: 2113410
-
Functional dopamine receptors in the brain.Neuropharmacology. 1984 Feb;23(2B):243-6. doi: 10.1016/0028-3908(84)90065-0. Neuropharmacology. 1984. PMID: 6369165 Review. No abstract available.
Cited by
-
Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.Cell Mol Neurobiol. 1992 Dec;12(6):597-606. doi: 10.1007/BF00711239. Cell Mol Neurobiol. 1992. PMID: 1490276 Free PMC article.
-
Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.Br J Pharmacol. 1992 Jan;105(1):27-36. doi: 10.1111/j.1476-5381.1992.tb14206.x. Br J Pharmacol. 1992. PMID: 1596688 Free PMC article.
-
Mono- and divalent cations modulate the affinities of brain D1 and D2 receptors for dopamine by a mechanism independent of receptor coupling to guanyl nucleotide binding proteins.Naunyn Schmiedebergs Arch Pharmacol. 1989 Apr;339(4):374-82. doi: 10.1007/BF00736050. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2500603
-
[O-methyl-11C]N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1H-indole-2-carboxamide ([11C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D₃ Receptors in Rodents and Monkey.Molecules. 2018 Oct 23;23(11):2737. doi: 10.3390/molecules23112737. Molecules. 2018. PMID: 30360553 Free PMC article.
-
Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine.Cell Mol Neurobiol. 1993 Jun;13(3):203-15. doi: 10.1007/BF00733750. Cell Mol Neurobiol. 1993. PMID: 8242685 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources